MICE which have been infected with a lymphomagenic virus (ULV), originally isolated from a urethane-induced lymphoma (Salaman, 1963) , can be shown to have developed new antigenicity in various tissues. Grafts of their skin are rejected by uninfected syngeneic mice, and furthermore, their spleen cells, when injected into the footpads of uninfected syngeneic recipients, cause enlargement of the draining popliteal lymph nodes (PLN) . No such responses are evoked in infected mice which are the recipients of tissues from either infected or uninfected mice (Salaman et al., 1972; Salaman, Turk and Wedderburn, 1973) .
PLN enlargement following footpad injection of spleen cells taken early in the preleukaemic phase is not specific for cells from ULV-infected donors: the same effect occurs when cells from mice infected with any one of several other leukaemogenic viruses are used. Similar effects, indicating the development of new antigenicity (" heterogenization ") in donor tissues, have been described for both oncogenic and non-oncogenic viruses by several authors (Breyere and Williams, 1964; Svet-Moldavsky et al., 1970; Holtermann and Majde, 1969) .
We have already shown that the nonreactivity of ULV-infected animals is at least partiallyr specific. While they do not respond with PLN enlargement to the footpad injection of spleen cells from similarly infected mice, they will respond normally to cells from mice infected with the lactate-dehydrogenase-elevating virus of Riley (LDV). The reverse is also true, in that LDV-infected mice respond to cells from ULV-, but not from LDV-infected animals (Wedderburn et al., in preparation) .
We wished to determine whether this non-reactivity of ULV-infected animals towards the prelymphomatous tissues of syngeneic animals infected with the same virus, would be paralleled by a decrease in resistance to the growth of malignant cells from a ULV-induced lymphoma (ULMC). We show that there was such a decrease in resistance in infected, compared with uninfected, recipients when ULMC were injected by the s.c. or i.m. route. Infected and uninfected mice were, however, equally susceptible to the growth of a methylcholanthrene-induced tumour, injected s.c.
MATERIALS AND METHODS
Mice.-Male BALB/c mice 8-12 weeks old were used; they were never more than 3 generations removed from a single-littermated line.
Virus.-Lymphomatous tissues from mice inoculated with ULV when newborn were passed through a sieve, twice centrifuged and stored at -70°C. Mice were infected by i.v. injection of 0-1 ml of this virus preparation.
ULV-induced malignant cell line.-The commonest neoplasm produced by ULV is a lymphoblastic lymphoma, but a few viral substrains have produced reticulum cell neoplasms. On 2 occasions, a disease indistinguishable from haemorrhagic Friend disease has developed (cf.Carteret al., 1970) . The latent period of ULV-induced lymphoma in adultinoculated BALB/c mice is seldom less than 3 months, and more usually 5-8 months. uniformly fatal. All the animals died with similar splenic involvement, but with longer survival times than mice which received the highest dose of cells.
Sixty to 90%o of mice which received 104, and about 500 of those which received 1 0-103, ULMC also died, but the findings in these groups were variable. In some animals gross splenic involvement developed, though more slowly; others presented with paralysed hind-legs, and a few developed hepatomegaly due to lymphomatous infiltrates. Fig. 1 shows a section through the spine of a paraplegic animal. In some of the paralysed mice the spleen was normal in size and appearance; others had spleens which were only slightly enlarged, containing 1-3 prominent discrete white foci of malignant cells, whereas confluent splenic involvement was invariably seen in the animals which had received large doses of ULMC.
PLN responses of normal and infected mice to s.c. injected ULMC In order to determine whether the responses of normal and infected mice to ULMC would be similar to those previously evoked by injection of prelymphomatous spleen cells (Salaman et al., 1973) , groups of 4 normal and 4 infected mice were injected with 107, 106, or 105 viable ULMC, or 107 X-rayed cells, into (Fig. 3) . In normal mice, the leukaemic infiltrate progressively declined, while the host-cell component increased markedly up to Day 15 (Fig. 4) (Fig. 6) ; it then slowly declined and pyroninophilic cells became prominent in the medullary cords and, to a lesser extent, the follicles (Fig. 7) . No leukaemic involvement was seen at any stage. The nodes were histologically inactive at Day 60.
In infected mice, the initial paracortical response was not maintained (Fig. 8) In order to determine whether ULVinfected animals would be more susceptible than normal mice to the s.c. injection of cells from an unrelated tumour, the responses of the 2 groups to a 3-methylcholanthrene-induced sarcoma were determined. When X-rayed Meth A cells were injected into normal and ULV infected animals, they produced the same degree of PLN enlargement in both groups, while X-rayed ULMC cells produced the expected difference in PLN weights between the groups. When live Meth A cells were injected s.c. there was no significant difference between the groups in the number of mice developing tumours, the time at which such tumours first appeared, or the rate of growth (Table III) .
Effect of injecting ULMC i.v. into UL Vinfected, and normal mice It was clear from preliminary experiments that the interaction between the growth of ULMC and the development of an immune response to these cells differed according to the route of administration. After i.v. injection, the number of animals Situations in which such new antigenicity, or "heterogenization ", has been demonstrated in animals which are either tumour-bearing, virus-infected, or both, can be divided into at least 2 categories. Mariani and her colleagues (reviewed by Mariani and Good, 1973) have produced considerable evidence that rejection of skin from tumour-bearing donors is related to the presence of a small number of tumour cells in the graft. In their opinion the rejection is " not of immunologic origin ": the course of rejection is unaltered by prior administration of 400R of whole-body irradiation to the recipients (Mariani, Maruyama and Good, 1972) . On the other hand, viruses such as lymphocytic choriomeningitis virus (1CM) (Holtermann and Majde, 1969) , or the skin-heterogenizing virus (SHV) described by Svet-Moldavsky and his colleagues (Svet-Moldavsky et al., 1970) appeared to have heterogenizing, without oncogenic, potential. In the case of SHV the proportion of virus-infected skin grafts rejected was reduced by prior administration of 400R to the recipients, and the survival time of those which were rejected was lengthened (Liozner, Svet-Moldavsky and Mkheidze, 1970) .
Recent work by several groups (Zinkernagel and Doherty, 1974; Koszinowski and Ertl, 1975; Garrido, Schirrmacher and Festenstein, 1976) suggests that such viral heterogenization may be a manifestation, either of alteration of antigens closely linked to histocompatilility antigens, or of the expression of such antigens themselves. In our own system, no tumours grew at the sites of either accepted or rejected skin grafts, nor were tumour cells seen in sections of the graft bed (Salaman et al., 1972) , although mice were watched for at least 6 months. We also observed that mice which had been infected with ULV were in all cases unable to reject heterogenized syngeneic grafts. Far from there being a second-set type of rejection by previously uninfected recipients which had rejected a first heterogenized graft, a second graft was often accepted (Salaman et al., 1972) . Our observation of PLN responses following injection of spleen cells from infected animals into the footpads of normal animals has given analogous results: significant enlargement occurs in normal, but not in infected recipients, which become non-reactive within 4-8 days of infection (Salaman et al., 1973) .
WVe show here that ULV-infected mice also failed to react by PLN enlargement to the injection into the footpads of Xrayed malignant cells induced by the infecting virus (Table I ). The possibility that this non-reactivity might be accompanied by decreased resistance to the growth of such malignant cells was also investigated. When ULMC were injected i.m. or s.c., there was a 10-100-fold difference in the minimum cell number for progressive growth, the virus-infected animals being the more susceptible. Moreover, histological examination showed that at the time of maximum activity in the T-cell-dependent paracortical zones of the PLNs in normal recipients (Day 9), there was very little activity in infected recipients. Malignant growth in the feet of the latter was already in advance of that in the former at this time, and by 15 and 22 days was clearly progressing, and eventually killed the animals by systemic spread. In the normal animals, which had shown a marked PLN reaction, tumours in the feet regressed, and all mice survived.
The question arose whether the above effect might be at least partly due to nonspecific immune depression, although ULV is not strongly immunodepressive during the preleukaemic period (Wedderburn, 1969) . The results using the Metlh A sarcoma, which indicated that ULVinfected animals responded by PLN enlargement to footpad injection of X-rayed Meth A cells, and did not show increased susceptibility to the growth of live Meth A cells injected s.c., make this explanation unlikely.
On the other hand, the effect of previous ULV infection on the growth of i.v. injected ULMC was to lengthen the mean survival time. However, the number of uninfected mice which die from tumour injected by this route is virtually independent of cell dose over a wide range, although the latent period is dose dependent; thus following i.v. injection of ULMC the immune response seems to be almost ineffectual as far as protection against malignant cell growth is concerned.
It seems likely that these results may be only a part of a complicated interaction between virus infection and malignant growth. S.c., as opposed to i.v. injection of ULV can give fairly effective immunization against both s.c.-and i.v.-injected ULMC (Wedderburn et al., in preparation; cf. Larson et al., 1973) . The inter-relationships of the phenomena described here, and the effects of a variety of immunizing procedures upon them, are the subject of further investigation.
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